Serum institute seeks permission to manufacture Sputnik V vaccine in India-India News , Firstpost
SII said it will be able to manufacture and supply 10 crore Covishield doses in June while also manufacturing Novavax.
The Serum Institute of India (SII) has applied to the Drug Controller General of India (DCGI) seeking permission to manufacture COVID-19
The SII has already told the government that it will be able to manufacture and supply 10 crore Covishield doses in June, while it is also manufacturing the Novavax vaccine, the regulatory clearance for which is awaited from the United States.
The vaccine was given emergency use authorisation (EUA) by the DCGI in April.
A consignment of 30 lakh doses of Sputnik V landed in Hyderabad on Tuesday.
Stay connected with us on social media platform for instant update click here to join our Twitter, & Facebook
We are now on Telegram. Click here to join our channel (@TechiUpdate) and stay updated with the latest Technology headlines.
For all the latest Technology News Click Here
For the latest news and updates, follow us on Google News.